595 related articles for article (PubMed ID: 34047916)
1. Acetyl-L-Carnitine Ameliorates Metabolic and Endocrine Alterations in Women with PCOS: A Double-Blind Randomized Clinical Trial.
Tauqir S; Israr M; Rauf B; Malik MO; Habib SH; Shah FA; Usman M; Raza MA; Shah I; Badshah H; Ehtesham E; Shah M
Adv Ther; 2021 Jul; 38(7):3842-3856. PubMed ID: 34047916
[TBL] [Abstract][Full Text] [Related]
2. Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial.
Hassan S; Shah M; Malik MO; Ehtesham E; Habib SH; Rauf B
Endocrine; 2023 Jan; 79(1):208-220. PubMed ID: 36169918
[TBL] [Abstract][Full Text] [Related]
3. Treatment with Metformin and Combination of Metformin Plus Pioglitazone on Serum Levels of IL-6 and IL-8 in Polycystic Ovary Syndrome: A Randomized Clinical Trial.
Ali DE; Shah M; Ali A; Malik MO; Rehman F; Badshah H; Ehtesham E; Vitale SG
Horm Metab Res; 2019 Nov; 51(11):714-722. PubMed ID: 31683341
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
Zhao H; Xing C; Zhang J; He B
Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
[TBL] [Abstract][Full Text] [Related]
6. Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial.
Zhang J; Xing C; Cheng X; He B
Front Endocrinol (Lausanne); 2022; 13():1003238. PubMed ID: 36147577
[TBL] [Abstract][Full Text] [Related]
7. Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial.
Li J; Ng EH; Stener-Victorin E; Hu Z; Shao X; Wang H; Li M; Lai M; Xie C; Su N; Yu C; Liu J; Wu T; Ma H
Trials; 2017 Mar; 18(1):115. PubMed ID: 28274268
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
9. Insulin Sensitizers Modulate GnRH Receptor Expression in PCOS Rats.
Patel R; Shah G
Arch Med Res; 2018 Apr; 49(3):154-163. PubMed ID: 30104075
[TBL] [Abstract][Full Text] [Related]
10. Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression.
Kashani L; Omidvar T; Farazmand B; Modabbernia A; Ramzanzadeh F; Tehraninejad ES; Ashrafi M; Tabrizi M; Akhondzadeh S
Psychoneuroendocrinology; 2013 Jun; 38(6):767-76. PubMed ID: 22999261
[TBL] [Abstract][Full Text] [Related]
11. SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial.
Garcia-Beltran C; Malpique R; Andersen MS; Bas F; Bassols J; Darendeliler F; Díaz M; Dieris B; Fanelli F; Fröhlich-Reiterer E; Gambineri A; Glintborg D; López-Bermejo A; Mann C; Marin S; Obermayer-Pietsch B; Ødegård R; Ravn P; Reinehr T; Renzulli M; Salvador C; Singer V; Vanky E; Torres JV; Yildiz M; de Zegher F; Ibáñez L
Trials; 2023 Sep; 24(1):589. PubMed ID: 37715279
[TBL] [Abstract][Full Text] [Related]
12. Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial.
Wen Q; Hu M; Lai M; Li J; Hu Z; Quan K; Liu J; Liu H; Meng Y; Wang S; Wen X; Yu C; Li S; Huang S; Zheng Y; Lin H; Liang X; Lu L; Mai Z; Zhang C; Wu T; Ng EHY; Stener-Victorin E; Ma H
Hum Reprod; 2022 Mar; 37(3):542-552. PubMed ID: 34907435
[TBL] [Abstract][Full Text] [Related]
13. Effects and plasma proteomic analysis of GLP-1RA versus CPA/EE, in combination with metformin, on overweight PCOS women: a randomized controlled trial.
Liao M; Li X; Zhang H; Zhou L; Shi L; Li W; Shen R; Peng G; Zhao H; Shao J; Wang X; Sun Z; Zheng H; Long M
Endocrine; 2024 Jan; 83(1):227-241. PubMed ID: 37653215
[TBL] [Abstract][Full Text] [Related]
14. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
15. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
16. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
17. l-Carnitine plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effects: a randomized clinical trial.
El Sharkwy I; Sharaf El-Din M
Gynecol Endocrinol; 2019 Aug; 35(8):701-705. PubMed ID: 30806102
[TBL] [Abstract][Full Text] [Related]
18. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
19. Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial.
Zhao H; Zhang J; Xing C; Cheng X; He B
J Ovarian Res; 2024 Feb; 17(1):42. PubMed ID: 38374053
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial.
Qian H; Xu W; Cui L; Wang R; Wang J; Tang M; Wei M; Wang L
Trials; 2021 Nov; 22(1):781. PubMed ID: 34743745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
